A recent study by our group has demonstrated that serum YKL-40 was an independent prognostic factor for OS and RFS in HCC patients undergoing curative resection and serial monitoring of serum YKL-40 after curative resection may provide additional prognostic information [16]. Here, CHI3L1 is linked to hepatocellular carcinoma.